Skip to Main Content

Paper Details

Clonal evolution in patients with chronic lymphocytic leukaemia developing resistance to BTK inhibition.
Nat Commun
261
2016
BTK, BTK-C481S, Bruton's tyrosine kinase, C481S, CD19, CD19-negative histiocytic sarcoma, EIF2A, EP300, Haploinsufficiency of TRAIL-R, MLL2, PLCG2 mutations, TRAIL, TRAIL-R, chronic lymphocytic leukaemia, del(8p), ibrutinib, ibrutinib-resistant subclones, patient, patients, rare subclones, tyrosine
Author NameAffiliation
Dan A LandauBroad Institute
Dan A Landau
Dan A Landau
Dan A Landau
Amaro Taylor-WeinerBroad Institute
Chip StewartBroad Institute
Chip StewartBroad Institute
Adrian M DubucBrigham and Women's Hospital and Harvard Medical School
Lihua ZouBroad Institute
Youzhong WanDana-Farber Cancer Institute
Carrie SougnezBroad Institute
Carrie SougnezBroad Institute
Scott L CarterBroad Institute
Kristian CibulskisBroad Institute
Peter V KharchenkoCenter for Biomedical Informatics, Harvard Medical School
Donna NeubergDana-Farber Cancer Institute
Hagop KantarjianMD Anderson Cancer Center
Eric S LanderBroad Institute
Eric S LanderBroad Institute
Stacey GabrielBroad Institute
Stacey GabrielBroad Institute
David A WeitzHarvard University
Gad GetzBroad Institute
Gad GetzBroad Institute
Catherine J WuBroad Institute
Catherine J WuDana-Farber Cancer Institute
Catherine J WuBrigham &Women's Hospital, Harvard Medical School
  • 1 - 27

Datasets

Release 1.2